Follow
Theodore Hong
Theodore Hong
Massachusetts General Hospital, Harvard Medical School
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Pancreatic adenocarcinoma
DP Ryan, TS Hong, N Bardeesy
New England Journal of Medicine 371 (11), 1039-1049, 2014
27072014
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ...
The Lancet Oncology 17 (6), 801-810, 2016
8852016
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer
CR Ferrone, G Marchegiani, TS Hong, DP Ryan, V Deshpande, ...
Annals of surgery 261 (1), 12-17, 2015
8452015
Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial
JE Murphy, JY Wo, DP Ryan, W Jiang, BY Yeap, LC Drapek, ...
JAMA oncology 4 (7), 963-969, 2018
5232018
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas
RJ Myerson, MC Garofalo, I El Naqa, RA Abrams, A Apte, WR Bosch, ...
International Journal of Radiation Oncology* Biology* Physics 74 (3), 824-830, 2009
5062009
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection?
IT Konstantinidis, AL Warshaw, JN Allen, LS Blaszkowsky, ...
Annals of surgery 257 (4), 731-736, 2013
4712013
Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic …
TS Hong, JY Wo, BY Yeap, E Ben-Josef, EI McDonnell, LS Blaszkowsky, ...
Journal of Clinical Oncology 34 (5), 460, 2016
4412016
Current management of gallbladder carcinoma
AX Zhu, TS Hong, AF Hezel, DA Kooby
The oncologist 15 (2), 168-181, 2010
4252010
Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial
JE Murphy, JY Wo, DP Ryan, JW Clark, W Jiang, BY Yeap, LC Drapek, ...
JAMA oncology 5 (7), 1020-1027, 2019
4092019
Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer
M Russo, G Siravegna, LS Blaszkowsky, G Corti, G Crisafulli, ...
Cancer discovery 6 (2), 147-153, 2016
4052016
Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline
AA Khorana, PB Mangu, J Berlin, A Engebretson, TS Hong, A Maitra, ...
Journal of Clinical Oncology 34 (21), 2541-2556, 2016
4032016
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
AR Parikh, I Leshchiner, L Elagina, L Goyal, C Levovitz, G Siravegna, ...
Nature medicine 25 (9), 1415-1421, 2019
3992019
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy
TS Hong, WA Tomé, RJ Chappell, P Chinnaiyan, MP Mehta, PM Harari
International Journal of Radiation Oncology* Biology* Physics 61 (3), 779-788, 2005
3682005
Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX
T Michelakos, I Pergolini, C Fernández-del Castillo, KC Honselmann, ...
Annals of surgery 269 (4), 733-740, 2019
3062019
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience
JE Faris, LS Blaszkowsky, S McDermott, AR Guimaraes, J Szymonifka, ...
The oncologist 18 (5), 543-548, 2013
3012013
Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis
R Tao, S Krishnan, PR Bhosale, MM Javle, TA Aloia, RT Shroff, AO Kaseb, ...
Journal of Clinical Oncology 34 (3), 219, 2016
2822016
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
A Dasari, VK Morris, CJ Allegra, C Atreya, AB Benson III, P Boland, ...
Nature reviews Clinical oncology 17 (12), 757-770, 2020
2612020
Minimal residual disease detection using a plasma-only circulating tumor DNA assay in patients with colorectal cancer
AR Parikh, EE Van Seventer, G Siravegna, AV Hartwig, A Jaimovich, Y He, ...
Clinical Cancer Research 27 (20), 5586-5594, 2021
2312021
Improved planning time and plan quality through multicriteria optimization for intensity-modulated radiotherapy
DL Craft, TS Hong, HA Shih, TR Bortfeld
International Journal of Radiation Oncology* Biology* Physics 82 (1), e83-e90, 2012
2302012
Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline update
AA Khorana, PB Mangu, J Berlin, A Engebretson, TS Hong, A Maitra, ...
Journal of Clinical Oncology 35 (20), 2324-2328, 2017
2242017
The system can't perform the operation now. Try again later.
Articles 1–20